These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 12135371)

  • 1. Peptides derived from BH3 domains of Bcl-2 family members: a comparative analysis of inhibition of Bcl-2, Bcl-x(L) and Bax oligomerization, induction of cytochrome c release, and activation of cell death.
    Shangary S; Johnson DE
    Biochemistry; 2002 Jul; 41(30):9485-95. PubMed ID: 12135371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence and helicity requirements for the proapoptotic activity of Bax BH3 peptides.
    Shangary S; Oliver CL; Tillman TS; Cascio M; Johnson DE
    Mol Cancer Ther; 2004 Nov; 3(11):1343-54. PubMed ID: 15542773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal BH3 peptides promote cell death by antagonizing anti-apoptotic proteins.
    Moreau C; Cartron PF; Hunt A; Meflah K; Green DR; Evan G; Vallette FM; Juin P
    J Biol Chem; 2003 May; 278(21):19426-35. PubMed ID: 12642586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-XL protects BimEL-induced Bax conformational change and cytochrome C release independent of interacting with Bax or BimEL.
    Yamaguchi H; Wang HG
    J Biol Chem; 2002 Nov; 277(44):41604-12. PubMed ID: 12198137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Bax-induced cytochrome c release from neural cell and brain mitochondria by dibucaine and propranolol.
    Polster BM; Basañez G; Young M; Suzuki M; Fiskum G
    J Neurosci; 2003 Apr; 23(7):2735-43. PubMed ID: 12684459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics.
    Letai A; Bassik MC; Walensky LD; Sorcinelli MD; Weiler S; Korsmeyer SJ
    Cancer Cell; 2002 Sep; 2(3):183-92. PubMed ID: 12242151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural biology of the Bcl-2 family of proteins.
    Petros AM; Olejniczak ET; Fesik SW
    Biochim Biophys Acta; 2004 Mar; 1644(2-3):83-94. PubMed ID: 14996493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly.
    Kuwana T; Bouchier-Hayes L; Chipuk JE; Bonzon C; Sullivan BA; Green DR; Newmeyer DD
    Mol Cell; 2005 Feb; 17(4):525-35. PubMed ID: 15721256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct addition of BimL to mitochondria does not lead to cytochrome c release.
    Terradillos O; Montessuit S; Huang DC; Martinou JC
    FEBS Lett; 2002 Jul; 522(1-3):29-34. PubMed ID: 12095614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-apoptotic Bcl-XL protein in complex with BH3 peptides of pro-apoptotic Bak, Bad, and Bim proteins: comparative molecular dynamics simulations.
    Lama D; Sankararamakrishnan R
    Proteins; 2008 Nov; 73(2):492-514. PubMed ID: 18452209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions.
    Finnegan NM; Curtin JF; Prevost G; Morgan B; Cotter TG
    Br J Cancer; 2001 Jul; 85(1):115-21. PubMed ID: 11437412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bak BH3 peptides antagonize Bcl-xL function and induce apoptosis through cytochrome c-independent activation of caspases.
    Holinger EP; Chittenden T; Lutz RJ
    J Biol Chem; 1999 May; 274(19):13298-304. PubMed ID: 10224090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between the antiapoptotic protein Nr-13 and cytochrome c. Antagonistic effect of the BH3 domain of Bax.
    Moradi-Améli M; Lorca T; Ficheux D; di Pietro A; Gillet G
    Biochemistry; 2002 Jul; 41(27):8540-50. PubMed ID: 12093270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-X(L) and calyculin A prevent translocation of Bax to mitochondria during apoptosis.
    Ganju N; Eastman A
    Biochem Biophys Res Commun; 2002 Mar; 291(5):1258-64. PubMed ID: 11883953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of apoptosis by BH3 domains in a cell-free system.
    Cosulich SC; Worrall V; Hedge PJ; Green S; Clarke PR
    Curr Biol; 1997 Dec; 7(12):913-20. PubMed ID: 9382837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-function analysis of Bcl-2 family proteins. Regulators of programmed cell death.
    Reed JC; Zha H; Aime-Sempe C; Takayama S; Wang HG
    Adv Exp Med Biol; 1996; 406():99-112. PubMed ID: 8910675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A common binding site mediates heterodimerization and homodimerization of Bcl-2 family members.
    Diaz JL; Oltersdorf T; Horne W; McConnell M; Wilson G; Weeks S; Garcia T; Fritz LC
    J Biol Chem; 1997 Apr; 272(17):11350-5. PubMed ID: 9111042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct domains of Bcl-XL are involved in Bax and Bad antagonism and in apoptosis inhibition.
    Zhou H; Hou Q; Chai Y; Hsu YT
    Exp Cell Res; 2005 Oct; 309(2):316-28. PubMed ID: 16061221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the anti-apoptotic mechanism of Bcl-B.
    Zhai D; Ke N; Zhang H; Ladror U; Joseph M; Eichinger A; Godzik A; Ng SC; Reed JC
    Biochem J; 2003 Nov; 376(Pt 1):229-36. PubMed ID: 12921534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular dynamics simulations of pro-apoptotic BH3 peptide helices in aqueous medium: relationship between helix stability and their binding affinities to the anti-apoptotic protein Bcl-X(L).
    Lama D; Sankararamakrishnan R
    J Comput Aided Mol Des; 2011 May; 25(5):413-26. PubMed ID: 21523491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.